The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Antigen-Specific Inhibition of CD8+ T Cell Response by Immature Myeloid Cells in Cancer Is Mediated by Reactive Oxygen Species
Abstract
Tumor growth is associated with the accumulation of immature myeloid cells (ImC), which in mice are characterized by the expression of Gr-1 and CD11b markers. These cells suppress Ag-specific CD8+ T cells via direct cell-cell contact. However, the mechanism of immunosuppressive activity of tumor-derived ImC remains unclear. In this study we analyzed the function of ImC isolated from tumor-free control and tumor-bearing mice. Only ImC isolated from tumor-bearing mice, not those from their control counterparts, were able to inhibit the Ag-specific response of CD8+ T cells. ImC obtained from tumor-bearing mice had significantly higher levels of reactive oxygen species (ROS) than ImC isolated from tumor-free animals. Accumulation of H2O2, but not superoxide or NO, was a major contributor to this increased pool of ROS. It appears that arginase activity played an important role in H2O2 accumulation in these cells. Inhibition of ROS in ImC completely abrogated the inhibitory effect of these cells on T cells, indicating that ImC generated in tumor-bearing hosts suppress the CD8+ T cell response via production of ROS. Interaction of ImC with Ag-specific T cells in the presence of specific Ags resulted in a significant increase in ROS production compared with control Ags. That increase was independent of IFN-γ production by T cells, but was mediated by integrins CD11b, CD18, and CD29. Blocking of these integrins with specific Abs abrogated ROS production and ImC-mediated suppression of CD8+ T cell responses. This study demonstrates a new mechanism of Ag-specific T cell inhibition mediated by ROS produced by ImCs in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 functions in an antioxidant pathway to prevent apoptosis
Hockenbery, D. M., Oltvai, Z. N., Yin, X.-M., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80066-n · Cited by 3,419
The Immunological Synapse: A Molecular Machine Controlling T Cell Activation
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M., & Dustin, M. L. (1999) · Science · doi:10.1126/science.285.5425.221 · Cited by 3,102
Arginine metabolism: nitric oxide and beyond
WU, G., & MORRIS, S. M. (1998) · Biochemical Journal · doi:10.1042/bj3360001 · Cited by 2,811
Inside the Neutrophil Phagosome: Oxidants, Myeloperoxidase, and Bacterial Killing
Hampton, M. B., Kettle, A. J., & Winterbourn, C. C. (1998) · Blood · doi:10.1182/blood.v92.9.3007 · Cited by 1,652
Almand, B., Clark, J. I., Nikitina, E., van Beynen, J., English, N. R., Knight, S. C., Carbone, D. P., & Gabrilovich, D. I. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.678 · Cited by 1,337
Self-citationProgress in human tumour immunology and immunotherapy
Rosenberg, S. A. (2001) · Nature · doi:10.1038/35077246 · Cited by 1,325
Killing activity of neutrophils is mediated through activation of proteases by K+ flux
Reeves, E. P., Lu, H., Jacobs, H. L., Messina, C. G. M., Bolsover, S., Gabella, G., Potma, E. O., Warley, A., Roes, J., & Segal, A. W. (2002) · Nature · doi:10.1038/416291a · Cited by 1,153
Reactive Oxygen Species as Intracellular Messengers During Cell Growth and Differentiation
Sauer, H., Wartenberg, M., & Hescheler, J. (2001) · Cellular Physiology and Biochemistry · doi:10.1159/000047804 · Cited by 1,118
Schmielau, J., & Finn, O. J. (2001) · PubMed · Cited by 867
Dynamic Imaging of T Cell-Dendritic Cell Interactions in Lymph Nodes
Stoll, S., Delon, J., Brotz, T. M., & Germain, R. N. (2002) · Science · doi:10.1126/science.1071065 · Cited by 718
Clinical significance of defective dendritic cell differentiation in cancer.
Almand, B., Resser, J. R., Lindman, B. R., Nadaf, S., Clark, J. I., Kwon, E. D., Carbone, D. P., & Gabrilovich, D. I. (2000) · PubMed · Cited by 699
Self-citationModolell, M., Corraliza, I. M., Link, F., Soler, G., & Eichmann, K. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250436 · Cited by 554
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Self-citationRegulation of T Cell Receptor CD3ζ Chain Expression byl-Arginine
Rodriguez, P. C., Zea, A. H., Culotta, K. S., Zabaleta, J., Ochoa, J. B., & Ochoa, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110675200 · Cited by 509
Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells
Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E., Dubois, C. M., Kopp, W. C., Longo, D. L., & Keller, J. R. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.1.22 · Cited by 464
Reactive oxygen species as essential mediators of cell adhesion
Chiarugi, P., Pani, G., Giannoni, E., Taddei, L., Colavitti, R., Raugei, G., Symons, M., Borrello, S., Galeotti, T., & Ramponi, G. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211118 · Cited by 444
Bronte, V., Chappell, D. B., Apolloni, E., Cabrelle, A., Wang, M., Hwu, P., & Restifo, N. P. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.10.5728 · Cited by 405
Kusmartsev, S. A., Li, Y., & Chen, S.-H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.2.779 · Cited by 355
Self-citationMyeloperoxidase: Contribution to the Microbicidal Activity of Intact Leukocytes
Klebanoff, S. J. (1970) · Science · doi:10.1126/science.169.3950.1095 · Cited by 346
Otsuji, M., Kimura, Y., Aoe, T., Okamoto, Y., & Saito, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.23.13119 · Cited by 338
Boucher, J. L., Moali, C., & Tenu, J. P. (1999) · Cellular and Molecular Life Sciences · doi:10.1007/s000180050352 · Cited by 316
Bronte, V., Wang, M., Overwijk, W. W., Surman, D. R., Pericle, F., Rosenberg, S. A., & Restifo, N. P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.10.5313 · Cited by 312
Immature myeloid cells and cancer-associated immune suppression
Kusmartsev, S., & Gabrilovich, D. I. (2002) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-002-0280-8 · Cited by 297
Self-citationChang, C., Liao, J. C., & Kuo, L. (2001) · PubMed · Cited by 294
Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species
Kusmartsev, S., & Gabrilovich, D. I. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103010 · Cited by 292
Self-citationWerner, E., & Werb, Z. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200111028 · Cited by 252
Tumor-Induced Immune Dysfunctions Caused by Myeloid Suppressor Cells
Bronte, V., Serafini, P., Apolloni, E., & Zanovello, P. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200111000-00001 · Cited by 250
Young, M. R., Newby, M., & Wepsic, H. T. (1987) · PubMed · Cited by 231
Boutard, V, Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J. P., & Baud, L. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.4.2077 · Cited by 186
Resection of Solid Tumors Reverses T Cell Defects and Restores Protective Immunity
Salvadori, S., Martinelli, G. P., & Zier, K. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.2214 · Cited by 144
Watanabe, Y., Suzuki, O., Haruyama, T., & Akaike, T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10501 · Cited by 108
Banas, B., Wörnle, M., Berger, T., Nelson, P. J., Cohen, C. D., Kretzler, M., Pfirstinger, J., Mack, M., Lipp, M., Gröne, H., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4301 · Cited by 95
Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers
Young, M. R., & Lathers, D. M. R. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(99)00008-9 · Cited by 95
Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., Wolf-Peeters, C. D., & Billiau, A. (1999) · PubMed · Cited by 95
Pardoll, D. M. (2001) · Nature · doi:10.1038/35082676 · Cited by 87
Superantigen-Induced CD4 T Cell Tolerance Mediated by Myeloid Cells and IFN-γ
Cauley, L. S., Miller, E., Yen, M., & Swain, S. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6056 · Cited by 87
Matthys, P., Vermeire, K., Mitera, T., Heremans, H., Huang, S., Schols, D., Wolf‐Peeters, C. D., & Billiau, A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.6.3503 · Cited by 84
Development of splenic natural suppressor (NS) cells in ehrlich tumor‐bearing mice
Subiza, J. L., Viñuela, J. E., Rodríguez, R., Gil, J., Figueredo, M. A., & de la Concha, E. G. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910440220 · Cited by 80
Rimbach, G. H., Valacchi, G., Canali, R., & Virgili, F. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0219 · Cited by 71
Watson, G. A., Fu, Y., & Lopez, D. M. (1991) · Journal of Leukocyte Biology · doi:10.1002/jlb.49.2.126 · Cited by 67
Endotoxemia and neutrophil activation in vivo
Grisham, M. B., Everse, J., & Janssen, H. F. (1988) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1988.254.5.h1017 · Cited by 65
Vladimirova, O. V., Lu, F. M., Shawver, L., & Kálmán, B. (1999) · Inflammation Research · doi:10.1007/s000110050480 · Cited by 58
Significance of arginase and ornithine in malignant tumors of the human skin
Gökmen, S. S., AYGIT, A. C., Ayhan, M. S., et al. (2001) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2001.114543 · Cited by 50
Possible implications of arginase and diamine oxidase in prostatic carcinoma.
Keskinege, A., Elgün, S., & Yilmaz, E. (2001) · PubMed · Cited by 48
Husemann, J., Obstfeld, A. E., Febbraio, M., Kodama, T., & Silverstein, S. C. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq0801.095150 · Cited by 38
Lajarin, F., Rubio, G., Lorenzo, N., Gámiz, P., Hernández‐Caselles, T., & García–Peñarrubia, P. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00148-3 · Cited by 21
Maas, R. A., Dullens, H. F. J., & Otter, W. D. (1992) · Immunology Today · doi:10.1016/0167-5699(92)90141-s · Cited by 17
Cited by
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Self-citationThe tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Regulation of immune responses by L-arginine metabolism
Bronte, V., & Zanovello, P. (2005) · Nature Reviews Immunology · doi:10.1038/nri1668 · Cited by 1,775
NRF2 and the Hallmarks of Cancer
Rojo de la Vega, M., Chapman, E., & Zhang, D. D. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.022 · Cited by 1,672
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Self-citation
Metadata
- Authors
- Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 172
- Issue
- 2
- Pages
- 989-999
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1580678794
- Cited by
- 850
- References
- 47
- FWCI
- 9.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.